Inflammation is an important factor promoting the progression of glioblastoma. In the present study we examined the contribution of Ras signaling and TNFa/IL-1b cytokines to the development of the glioblastoma inflammatory microenvironment. Enhanced activation of Ras through de-regulated activation of receptor tyrosine kinases, such as EGFR, PDGFR and cMet, is a hallmark of the majority of glioblastomas. Glioblastoma microenvironment contains high levels of TNFa and IL-1b, which mediate inflammation through induction of a local network of cytokines and chemokines. While many studies have focused on Ras-and TNFa/IL-1b-driven inflammation in isolation, little is known about the co-operation between these oncogenic and microenvironment-derived stimuli. Using constitutively active HRasG12V that mimics enhanced Ras activation, we demonstrate that elevated Ras activity in glioblastoma cells leads to up-regulation of IL-6 and IL-8. Furthermore, Ras synergizes with the microenvironment-derived TNFa and IL-1b resulting in amplified IL-6/IL-8 secretion. IL-8 secretion induced by Ras and TNFa/IL-1b is attenuated by inhibitors targeting Erk, JNK and p38 MAPK pathways. IL-6 secretion significantly decreased upon inhibition of JNK and p38 MAPK pathways. Interestingly, although constitutively active HRasG12V does not increase basal or TNFa/IL-1b stimulated p38 MAPK activity, HRasG12V increased the efficacy of the p38 MAPK inhibitor SB203580 to inhibit IL-1b-induced IL-6 secretion. In summary, oncogenic Ras co-operates with the microenvironment-derived TNFa/IL-1b to sustain inflammatory microenvironment, which was effectively attenuated via inhibition of p38 MAPK signaling.